Latest stories on RARE
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update | RARE Stock News
StockTitan50 · neutralgeneral
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RARE Stock News
StockTitan50 · neutralgeneral
Ultragenyx: The Setrusumab Reset Creates A Cleaner Rare Disease Opportunity
Seeking Alpha63 · neutralproduct/pr
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RARE Stock News
StockTitan50 · neutralgeneral
Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks
Yahoo Top66 · bullishanalyst
Ultragenyx Pharmaceutical Inc. (RARE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)
Yahoo Top68 · bullishanalyst
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
PR Newswire34 · bearishgeneral
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference | RARE Stock News
StockTitan50 · neutralgeneral
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Yahoo Top38 · neutralgeneral
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RARE Stock News
StockTitan50 · neutralgeneral
Rare disease families find roadmap to drug development at bootcamps
CNBC56 · neutralproduct/pr